Strategy acceleration Mon, Sep 13, 2021 11:36 CET Novo Nordisk is a global pharmaceutical company with more than 95 years of innovation and leadership within diabetes treatment. We have interviewed Niels Abel Bonde, Managing Director at Novo Nordisk, to get his perspective on strategy acceleration. Low resolution Medium resolution Original resolution
